Live Breaking News & Updates on Q4 numbers

Axis Bank writes off Rs 2,082 crore of loans in January-March quarter

During the quarter, the net NPAs declined to 0.31 percent from 0.36 percent in the preceding quarter. Also, recoveries from written off accounts stood at Rs 919 crore.

Gross-npas , Axis-bank-on , Axis-bank , Citi-bank-india , Axis-bank-gross , Citi-bank , Q4-numbers , Loan-write-off ,

Neogen Chem plunges 5% on disappointing quarterly performance

Neogen Chemicals also has a slew of capacity expansion plans under the pipeline, with an estimated cost of around Rs 450 crore.

India , Japan , National-stock-exchange , Neogen-chemicals , Neogen-chemcials , Buli-chemicals-india , Uzzing-stocks , 4-earnings , 4-results , Q4-numbers , Chemical-company

Dr Reddy's fall 5% even after Q4 net profit jumps 10-fold. Here's why

Despite the huge jump, Dr Reddy s net profit for the fourth quarter lagged Street s estimate and brokerages are concerned about the firm s growth map

Hyderabad , Andhra-pradesh , India , Prabhudas-lilladher , Goldman-sachs , Motilal-oswal-financial-services , Oswal-financial-services , Dr-reddys-laboratories , Dr-reddy-s , Rugmaker , Harmaceutical-company , Harma

Lupin's Q4 net profit at Rs 236 crore, sales rise 12.1% YoY

An improved product mix also helped Lupin expand its EBIDTA margin for the quarter by 690 basis points on year.

India , Nilesh-gupta , Earnings-before-interest , Managing-director , Results , Upin , 4-results , Q4-numbers , 4-earnings , Lupin-q4 , Rugmaker

US sales, brand deals to seal the fortune for Dr Reddy's in Q4

Dr Reddy s is poised to reap the benefits of brand sales of Rs 275 crore, which will incrementally boost its headline numbers for Q4.

Prabhudas-lilladher , Jm-financial-services , Drug-administration , Axis-securities , Earnings-before-interest , Dr-reddys-laboratories , 4-earnings , Rugmaker , Revlimid , S-market , Pharma-company , Harmaceutical

One-time loss, weak operational performance drags UPL Q4 earnings below street expectations

The company also missed the target to reduce its net debt by $500 million during FY22-23. Going ahead, UPL has guided a revenue growth of 6-10 percent and an EBIDTA growth of 8-12 percent.

United-states , American , America , Mike-frank , Latin-american , Latin-america , Chief-executive-officer , Crop-protection , Dupl-ltd , Arnings , 4-earnings

Chemicals Q4 preview: A mixed bag, agri-input companies seen weak, specialty chemicals firms may grow

Despite the near-term headwinds for the chemicals sector, the street s long-term view remains positive due to the strong prospects for specialty chemicals and a huge import replacement opportunity.

China , Godrej-agrovet , Kotak-institutional-equities , Navin-flourine , Elara-capital , Vinati-organics , China-plus-one , Earnings , 4-earnings , 4-results , Q4-numbers

Axis Bank posts loss of Rs 5,728.42 crore on Citi Bank deal, here's what brokerages say

Axis Bank s bottomline was hit by the cost of purchasing Citi Bank s India consumer business, excluding which, it posted a significant 61 percent on-year growth

India , Motilal-oswal , Citi-bank-india , Citibank , Financial-services , Axis-bank-on , Axis-bank , Citi-bank , Citicorp-finance , Common-equity-tier , Institutional-equities , Nuvama-institutional-equities